Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts.
Dieden A, Girerd N, Ottosson F, Molvin J, Pareek M, Melander O, Bachus E, Råstam L, Lindblad U, Daka B, Leósdóttir M, Nilsson PM, Olsen MH, Clark AL, Cleland JGF, Delles C, González A, Lamiral Z, Duarte K, Rossignol P, Zannad F, Gudmundsson P, Jujić A, Magnusson M. Dieden A, et al. Among authors: bachus e. Eur J Heart Fail. 2024 Oct 28. doi: 10.1002/ejhf.3502. Online ahead of print. Eur J Heart Fail. 2024. PMID: 39466935
Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER.
Abdin A, Kondo T, Böhm M, Jhund PS, Claggett BL, Vaduganathan M, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Desai AS, Køber L, Sabatine MS, Petersson M, Bachus E, Solomon SD, McMurray JJV;  on behalf of the DAPA‐HF and DELIVER Committees and Investigators. Abdin A, et al. Among authors: bachus e. Eur J Heart Fail. 2024 Sep;26(9):1952-1963. doi: 10.1002/ejhf.3350. Epub 2024 Jul 17. Eur J Heart Fail. 2024. PMID: 39016033
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
Yang M, Kondo T, Talebi A, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Køber L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV. Yang M, et al. Among authors: bachus e. Eur J Heart Fail. 2024 Jul;26(7):1524-1538. doi: 10.1002/ejhf.3263. Epub 2024 May 3. Eur J Heart Fail. 2024. PMID: 38700986 Clinical Trial.
Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER.
Butt JH, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Køber L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV. Butt JH, et al. Among authors: bachus e. JACC Heart Fail. 2024 Sep;12(9):1586-1599. doi: 10.1016/j.jchf.2024.01.018. Epub 2024 Apr 3. JACC Heart Fail. 2024. PMID: 38573262 Free article.
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction.
McDowell K, Kondo T, Talebi A, Teh K, Bachus E, de Boer RA, Campbell RT, Claggett B, Desai AS, Docherty KF, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Simpson J, Vaduganathan M, Jhund PS, Solomon SD, McMurray JJV. McDowell K, et al. Among authors: bachus e. JAMA Cardiol. 2024 May 1;9(5):457-465. doi: 10.1001/jamacardio.2024.0284. JAMA Cardiol. 2024. PMID: 38536153 Free PMC article.
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER.
Kondo T, Butt JH, Curtain JP, Jhund PS, Docherty KF, Claggett BL, Vaduganathan M, Bachus E, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Køber L, Ponikowski P, Sabatine MS, Solomon SD, McMurray JJV. Kondo T, et al. Among authors: bachus e. Circ Heart Fail. 2023 Dec;16(12):e010898. doi: 10.1161/CIRCHEARTFAILURE.123.010898. Epub 2023 Oct 27. Circ Heart Fail. 2023. PMID: 37886880
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER.
Butt JH, Lu H, Kondo T, Bachus E, de Boer RA, Inzucchi SE, Jhund PS, Kosiborod MN, Lam CSP, Martinez FA, Vaduganathan M, Solomon SD, McMurray JJV. Butt JH, et al. Among authors: bachus e. Eur J Heart Fail. 2023 Nov;25(11):2078-2090. doi: 10.1002/ejhf.3000. Epub 2023 Sep 1. Eur J Heart Fail. 2023. PMID: 37634087 Free article. Clinical Trial.
Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
Kondo T, Wang X, Yang M, Jhund PS, Claggett BL, Vaduganathan M, Hernandez AF, Lam CSP, Inzucchi SE, Martinez FA, de Boer RA, Kosiborod MN, Desai AS, Køber L, Ponikowski P, Sabatine MS, Langkilde AM, Petersson M, Zaozerska N, Bachus E, Solomon SD, McMurray JJV. Kondo T, et al. Among authors: bachus e. J Am Coll Cardiol. 2023 Sep 5;82(10):1014-1026. doi: 10.1016/j.jacc.2023.05.056. Epub 2023 Aug 21. J Am Coll Cardiol. 2023. PMID: 37610398 Free article.
44 results